Madison, Wis. — OpGen, a gene sequencing company with 30 employees in Madison, is opening a new headquarters in Montgomery County in Maryland and plans to expand to 70 employees there in a year....
Product and company acquisitions at premium prices by product- and technology-hungry Big Pharma and Big Device (and even Big Biotech) are fueling the financial coffers of both smaller companies, investors and VCs....
Swiss pharmaceutical company Roche Holdings is continuing its Madison buying spree by acquiring Madison-based Mirus Bio for $125 million. In this update: Mirus' funding model — no venture capital — the significance to Wisconsin's biotech industry, and Roche's possible intention to become the biggest biotech...
Breaking News — Madison, Wis. — Roche announced today that it is buying Mirus Bio Corporation for $125 million, one year after acquiring NimbleGen, also a Madison-based company....
Milwaukee, Wis. — The Medical College of Wisconsin has received a four-year, $2 million grant from a division of the National Institutes of Health that will extend a long-standing project through its 33rd year....
Madison, Wis.—The patent dispute between two organizations and the Wisconsin Alumni Research Foundation isn't over yet: The groups filed an appeal today to have a key stem-cell patent overturned after its claims were narrowed, but upheld....
Madison, Wis. — Using a $1.6 million federal grant, the University of Wisconsin-Madison is adding to its collection of large scientific instruments a device that will help it search for new antibiotics and drugs and perform other research....
In 2004, the nation took notice as California and Wisconsin independently announced major investments in stem cell and biotechnology research. Four years later—as a comparison to California, Maryland, Massachusetts and New Jersey shows—Wisconsin clearly has room to realize a better return on its investment....
The recent BIO International 2008 conference (it should really be called the BIO Global conference), held in San Diego, demonstrated the extent to which the biotech industry has globalized. As BIO noted in its wrap-up comments about the industry, the biotech industry is poised to...
Madison, Wis. — Mithridion has leveraged the acquisition of an Ohio biotech company to move into its first clinical trial, for a drug that might slow or stop the processes that kill brain cells in patients with Alzheimer's disease....